These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6483889)

  • 1. Modification in the antibody-dependent cellular cytotoxicity as influenced by chemicals.
    Lawman MJ; Bell JU
    Prog Clin Biol Res; 1984; 161():265-88. PubMed ID: 6483889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct mechanisms of cytotoxicity by porcine alveolar macrophages in antibody-dependent and immobilized immune complex-dependent cellular cytotoxicity.
    Rothlein R; Kim YB
    J Immunol; 1983 Sep; 131(3):1438-42. PubMed ID: 6687337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity.
    van Meerten T; van Rijn RS; Hol S; Hagenbeek A; Ebeling SB
    Clin Cancer Res; 2006 Jul; 12(13):4027-35. PubMed ID: 16818702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE; Muchmore AV; Blaese RM
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features, genetics and in vivo importance of lymphocyte mediated natural cytotoxicity.
    Petrányi GG; Györffy G; Benczur M; Varga M; Gyódi E; Onody K; Füst G; Láng I
    Panminerva Med; 1978; 20(1):71-80. PubMed ID: 643304
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R; Hatanaka S; Shoji-Hosaka E; Sakurada M; Kobayashi Y; Uehara A; Yokoi H; Nakamura K; Shitara K
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
    Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
    Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-induced suppression of antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood mononuclear cells.
    Gergely P; Láng I; Kalmár L; González-Cabello R
    Acta Med Acad Sci Hung; 1980; 37(4):389-94. PubMed ID: 7234306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the immune response by plasma protease inhibitors III. Alpha 1-antichymotrypsin inhibits human natural killing and antibody-dependent cell-mediated cytotoxicity.
    Gravagna P; Gianazza E; Arnaud P; Neels M; Ades EW
    J Reticuloendothel Soc; 1982 Aug; 32(2):125-30. PubMed ID: 6897659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
    Petri IB; Szekeres E; Varga E; Berek I; Molnár J; Berek L; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(3A):1247-50. PubMed ID: 8702245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of immunomodulatory drugs on the cytotoxicity induced by monoclonal antibody 17-1A and interleukin-2.
    Flieger D; Varvenne M; Kleinschmidt R; Schmidt-Wolf IG
    Cell Immunol; 2007 Mar; 246(1):26-33. PubMed ID: 17562330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.
    Chen Z; Freedman MS
    Clin Immunol; 2008 Aug; 128(2):219-27. PubMed ID: 18501678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
    Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
    Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of gamma-interferon and phorbol myristate acetate on the Fc gamma-receptor ligand-binding capacity and on the target-conjugating and antibody-dependent cytotoxic activity of blood lymphocytes].
    Miliukiene VV; Dediniene JL
    Tsitologiia; 1997; 39(8):681-7. PubMed ID: 9490506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma.
    Cardarelli PM; Moldovan-Loomis MC; Preston B; Black A; Passmore D; Chen TH; Chen S; Liu J; Kuhne MR; Srinivasan M; Assad A; Witte A; Graziano RF; King DJ
    Clin Cancer Res; 2009 May; 15(10):3376-83. PubMed ID: 19401346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.